At NEST, we are dedicated to providing safe, clean, and high-quality pharmaceutical packaging and medical devices. Our global supply chain, combined with our ability to offer customizable services

n 2022, the U.S. Food and Drug Administration (FDA) granted its first approval for the use of organoid and organ-on-a-chip technologies in new drug development research, marking a milestone in the field of biomedical research.

On September 21, we held a grand ceremony to mark the first shipment of NEST pen injectors produced at our , facility to our U.S. headquarters.

Following the FDA 510(k) clearance of NEST Repeatable Pen Injector, NEST Disposable Pen Injector Landed U.S. Food and Drug Administration (FDA) 510(k) Letter!

Article Title：Bacteria-Anchoring Hybrid Liposome Capable of Absorbing Multiple Toxins for Antivirulence Therapy of Escherichia coli Infection. Author：Lixian Jiang Journal Title：ACS Nano Impact Factor：30.083